Why High-Dose NMN May Be Backfiring — What the Research Actually Shows
Vorschaubild von YouTube. Abspielen lädt den YouTube-Player.
Verlauf & EmpfehlungenAus
Zuletzt angesehene Inhalte in diesem Browser behalten. Dein Verlauf bleibt auf diesem Gerät und wird nicht an Harbor gesendet. Abgespielte Videos können auch passende Videoempfehlungen sortieren.
Merkliste & Verlauf öffnen →Über dieses Video
Creator-Beschreibung · OriginaltextTextsprache: Englisch
David Sinclair takes one gram of NMN daily. The human trials with the
best functional outcomes used 250 milligrams. Most people are somewhere
in between — based on what they read, not what the research shows.
This video breaks down:
• What dose the major human NMN trials actually used (and what they found)
• The CD38 "ceiling effect" that limits returns at high doses
• The 2023 Nature Metabolism paper on NAD+ and cancer cells (and what it actually means)
• Why Sinclair's one-gram dose is self-selected, not clinically derived
• Peter Attia's position on NMN — and why it's also reasonable
• Age-based dosing breakdown: under 45, 45–65, 65+
---
TIMESTAMPS
0:00 — The NMN dose question: is 1 gram actually better?
0:35 — Why “more NMN = more benefit” is not always true
1:28 — What this video is — and is not — saying about NMN safety
2:06 — Major human NMN trials and the doses they actually tested
3:14 — 2024 meta-analysis: where functional benefits appear strongest
3:55 — The cancer-metabolism concern around high NAD+ levels
5:21 — CD38: the “NAD+ vampire” and the ceiling effect
6:50 — Why David Sinclair takes 1 gram — and what that really means
7:37 — Peter Attia’s more cautious position on NMN
8:05 — Why age changes the ideal NMN dose
9:17 — Practical NMN dose guide by age group
9:55 — Cancer history: talk to your oncologist before NAD+ precursors
10:07 — Timing and absorption still matter regardless of dose
10:20 — Next topic: why NMN brand quality matters
---
STUDIES REFERENCED
• NMN 250mg RCT in older men — Keio University, 2021 (Cell Metabolism)
• NMN 1,000mg trial in postmenopausal women — Washington University, 2022
• MIB-626 (NMN) high-dose trial — 2023
• NAD+ and cancer metastasis — Nature Metabolism, 2023
• NMN human trial meta-analysis — npj Aging, 2024
---
DISCLAIMER — AI CONTENT & HEALTH
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
AI CONTENT: This video features an AI-generated presenter
(Dr. James Chen), AI voiceover, and AI-assisted visuals.
Dr. James Chen is a synthetic AI wellness educator —
not a real person or licensed physician.
HEALTH: All content is for educational purposes only and
does not constitute medical advice, diagnosis, or treatment.
Consult a qualified healthcare provider before starting any
supplement protocol or making significant lifestyle changes —
especially if you are pregnant, nursing, on medication,
or managing a chronic condition.
Individual results vary. Studies referenced are linked above.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
---
Longevity Lab covers the science of aging without supplement
industry spin. New video every week.
```
Longevity Lab · 11 min · Quelle veröffentlicht: 2026-05-18
Zu Harbor hinzugefügt: 23.10.2026
Original auf YouTube ↗Automatisch eingeordnete Quelle. Creator-Aussagen sind keine unabhängige Evidenzprüfung und keine persönliche medizinische Beratung.